We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...

The DNA microarray is the latest in a line of techniques to exploit a potent feature of the DNA duplex—the sequence complementarity of the two strands. It is remarkable that a molecule of such great ...

Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...

This infographic explores the key multiomics fields, their integration across research applications, and real-world case ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD ...

Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly ...

Mitchell Grant is a self-taught investor with over 5 years of experience as a financial trader. He is a financial content strategist and creative content editor. Suzanne is a content marketer, writer, ...

The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...

Researchers detected Usutu virus RNA in nine of 818 wild carnivores sampled across the Netherlands, while no animals tested ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Comparable company analysis (CCA) is a method for assessing a company’s worth by ...

The U.S. Life Science Tools Market is projected to grow from USD 68.50 Billion in 2025 to USD 189.48 Billion by 2035, while ...